MAUDE Adverse Event Report: ENCORE MEDICAL L.P. RSP SHOULDER; BASEPLATE, GLENOID HA-COAT, RSP, 6.5MM X 30MM

Model Number	508-00-436
Health Effect - Clinical Code	Unspecified Infection (1930)
Date of Event	11/29/2016
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
This product complaint was discovered during a review of a legal claim.It was submitted via email by the legal department to the djo surgical contact in quality assurance.This quality assurance contact passed away shortly after receiving the complaint and no other djo surgical personnel was made aware of this issue until (b)(4) 2018.Changes are being put in place to ensure that these types of notifications will be sent to more than one individual in the quality assurance and regulatory affairs departments.
Event or Problem Description
Complaint - due to an infection.
Additional Manufacturer Narrative
The reason for this revision surgery was reported as an infection.The date of the surgery is unknown therefore the time in vivo could not be determined.No information was submitted with the complaint regarding pre-existing conditions of the patient or any activities the patient was involved in that may have contributed to the infection or inhibited the patient's immune system.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was disposed of at the hospital and not made available to djo surgical for examination.A review of the implant device history records (dhrs) show that the reported component used in the previous surgery met design and manufacturing requirements.There were no non-conforming material reports (ncmrs) associated with the product that may have contributed to an infection.Customer complaint history of the reported device showed no present trends or on-going issues that are in need of review.The device was verified to have gone through an acceptable sterilization process and was within it's expiration date at the time of use during the previous surgery.There were no findings during this investigation that indicate that the reported device was the root cause or had a direct connection with the patient's infection.There are multiple factors that may contribute to an infection that are outside of the control of djo surgical.There are no indications of a product or process issue affecting implant safety or effectiveness.
Additional Manufacturer Narrative
Corrected data: primary component changed after receiving additional information.Manufacturer narrative: the reason for this revision surgery was due to an infection.The previous surgery and the revision detailed in this investigation occurred 3.9 years apart.No information was submitted with the complaint regarding pre-existing conditions of the patient or any activities the patient was involved in that may have contributed to the infection or inhibited the patient's immune system.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was disposed of at the hospital and not made available to djo surgical for examination.A review of the implant device history records (dhrs) show that the reported component used in the previous surgery met design and manufacturing requirements.There were no non-conforming material reports (ncmrs) associated with the product that may have contributed to an infection.Customer complaint history of the reported device showed no present trends or on-going issues that are in need of review.The device was verified to have gone through an acceptable sterilization process and was within it's expiration date at the time of use during the previous surgery.The root cause of this complaint was a revision surgery due to an infection.There were no findings during this investigation that indicate that the reported device was the root cause or had a direct connection with the patient's infection.There are multiple factors that may contribute to an infection that are outside of the control of djo surgical.There are no indications of a product or process issue affecting implant safety or effectiveness.

• Brand Name: RSP SHOULDER
• Common Device Name: BASEPLATE, GLENOID HA-COAT, RSP, 6.5MM X 30MM
• Manufacturer (Section D): ENCORE MEDICAL L.P.; 9800 metric blvd; austin TX 78758 5445
• MDR Report Key: 7382992
• Report Number: 1644408-2018-00285
• Device Sequence Number: 19210641
• Product Code: PHX
• UDI-Device Identifier: 00888912024686
• UDI-Public: (01)00888912024686
• Combination Product (Y/N): N
• Initial Reporter State: CA
• Initial Reporter Country: US
• PMA/510(K) Number: K051075
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2012
• Device Explanted Year: 2016
• Reporter Type: Manufacturer
• Report Source: company representative
• Initial Reporter Occupation: Other
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 05/22/2018

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 08/28/2018
• Device Model Number: 508-00-436
• Device Catalogue Number: 508-32-104
• Device Lot Number: 866C1373
• Was Device Available for Evaluation?: No
• Was the Report Sent to FDA?: No
• Initial Date Received by Manufacturer: 12/04/2017
• Supplement Date Received by Manufacturer: 04/11/2018; 05/22/2018
• Initial Report FDA Received Date: 03/29/2018
• Supplement Report FDA Received Date: 04/12/2018; 05/22/2018
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: 415-00-120, LOT 7712141-12; 415-00-120, LOT 7716131; 506-00-010, LOT 816C1100; 506-03-114, LOT 831C1343; 506-03-114, LOT 831C1351; 506-03-118, LOT 832C1073; 506-03-122, LOT 833C1074; 506-03-122, LOT 833C1277; 506-03-126, LOT 834C1072; 506-03-126, LOT 834C1299; 506-03-130, LOT 835C1048; 508-00-000, LOT 848C1292; 508-00-032, LOT 855C1161; 508-32-101, LOT 862C1180; 508-32-204, LOT 769P1195; 508-36-101, LOT 869C2122; 510-00-012, LOT 981F1262; 415-00-120, LOT 7716131; 506-03-114, LOT 831C1343; 506-03-114, LOT 831C1351; 506-03-122, LOT 833C1277; 506-03-126, LOT 834C1299; 508-32-204, LOT 769P1195; 508-36-101, LOT 869C2122; 510-00-012, LOT 981F1262
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 72 YR